A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers Jon B. Bishop, MD, Linda G. Phillips, MD, Thomas A. Mustoe, MD, A.John VanderZee, MD, Laurel Wiersema, RN, MSN, Dell E. Roach, RN, BSN, John P. Heggers, PhD, Donald P. Hill, PharmD, Eugene L. Taylor, Martin C. Robson, MD Journal of Vascular Surgery Volume 16, Issue 2, Pages 251-257 (August 1992) DOI: 10.1016/0741-5214(92)90115-O Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions
Fig. 1 Patient treated with 1% silver sulfadiazine cream (Silvadene) at beginning (A,B) and completion (C,D) of study. Journal of Vascular Surgery 1992 16, 251-257DOI: (10.1016/0741-5214(92)90115-O) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions